CDH1 and cancer: In addition, EZH2 promotes epithelial–mesenchymal transition (EMT), a process that is associated with cancer progression and metastasis, by interacting with transcription factor SNAIL1 and suppressing expression of epithelial marker E-cadherin (CDH1) (Cao et al, 2008; Table 2).